10-K: P&G Reports Strong FY25 Earnings Amid Restructuring

Sentiment:

Annual Report


Procter & Gamble reported increased net earnings and diluted EPS for fiscal year 2025, driven by reduced selling, general, and administrative costs and the absence of a prior-year impairment charge, despite ongoing restructuring efforts.

Capital raiseThe company financed its share repurchases through a combination of operating cash flows and the issuance of debt.It maintains bank credit facilities totaling $8.0 billion to support its commercial paper program, which are currently undrawn.An automatically effective registration statement on Form S-3 is available for registered offerings of shortor long-term debt securities.
Better than expectedNet earnings increased by 7% and diluted EPS increased by 8%, indicating strong profitability growth.Operating income increased by 10%, driven by effective cost management (reduced SG&A) and the absence of a significant impairment charge from the prior year.Core EPS, which provides a clearer view of sustainable performance, also increased by 4%.

Summary

  • Net sales increased by $245 million to $84.3 billion in fiscal year 2025, primarily due to pricing, offset by unfavorable foreign exchange.
  • Organic sales, excluding acquisitions, divestitures, and foreign exchange, increased by 2%, with low single-digit growth across all Sector Business Units.
  • Operating income rose by 10% to $20.5 billion, benefiting from lower selling, general, and administrative (SG&A) costs and the absence of the prior year's $1.3 billion Gillette intangible asset impairment charge.
  • Net earnings increased by 7% to $16.1 billion, and diluted EPS grew by 8% to $6.51.
  • Core EPS, which excludes incremental restructuring charges and the Gillette impairment, increased by 4% to $6.83.
  • Cash flow from operating activities decreased by 10% to $17.8 billion, while adjusted free cash flow was $14.6 billion, a 14% decrease.
  • Adjusted free cash flow productivity was 87%, down from 105% in the prior year.
  • The company announced a portfolio and productivity plan in June 2025, expecting to incur $1.5 billion to $2.0 billion in before-tax restructuring costs over two years, including a reduction of up to 7,000 non-manufacturing overhead personnel by the end of fiscal 2027.
  • The Glad joint venture agreement will not be renewed, with The Clorox Company purchasing P&G's minority interest for approximately $500 million, expected to result in an after-tax gain of $250 million to $300 million in the third quarter of fiscal year 2026.

Sentiment

Score: 7

Explanation: The company delivered solid financial results with increased earnings and EPS, driven by productivity and cost management. Strategic restructuring and portfolio optimization are underway, and the company maintains strong market positions and financial health. However, operating cash flow and adjusted free cash flow productivity declined, and macroeconomic headwinds, foreign exchange impacts, and ongoing restructuring costs present challenges.

Positives

  • Net sales increased to $84.3 billion in fiscal 2025.
  • Operating income increased by $1.9 billion, or 10%, to $20.5 billion.
  • Net earnings increased by $1.1 billion, or 7%, to $16.1 billion.
  • Diluted EPS increased by 8% to $6.51.
  • Core EPS increased by 4% to $6.83.
  • Organic sales grew by 2%, with low single-digit increases across all Sector Business Units.
  • SG&A as a percentage of net sales decreased by 80 basis points due to decreased marketing spending and productivity savings.
  • Manufacturing productivity savings contributed 180 basis points to gross margin.
  • The company has paid a dividend for 135 consecutive years and increased it for 69 consecutive years.
  • Maintained strong shortand long-term debt ratings (P-1/A-1+ from Moody's/S&P for short-term; Aa3/AAfrom Moody's/S&P for long-term), enabling access to capital markets.

Negatives

  • Net sales in Beauty decreased low single digits, and the segment's net earnings decreased 8%.
  • Gross margin decreased by 20 basis points to 51.2% of net sales, primarily due to unfavorable product mix, product and packaging investments, higher commodity costs, and unfavorable foreign exchange.
  • Cash flow from operating activities decreased by 10% to $17.8 billion.
  • Adjusted free cash flow decreased by 14% to $14.6 billion.
  • Adjusted free cash flow productivity was 87%, down from 105% in the prior year.
  • Working capital and other impacts consumed $2.5 billion of cash, with inventories increasing and accounts payable decreasing.
  • Incurred $1.1 billion in before-tax restructuring costs in fiscal 2025, including a non-cash charge of $752 million for accumulated foreign currency translation losses due to the substantial liquidation of operations in Argentina.
  • The Gillette indefinite-lived intangible asset had a $1.3 billion before-tax ($1.0 billion after-tax) non-cash impairment charge in the prior fiscal year (FY24), and its fair value still exceeds its carrying value by only greater than 10% as of December 31, 2024, indicating sensitivity to adverse changes.

Risks

  • Global financial risks, including foreign currency fluctuations, changes in global interest rates, currency exchange or pricing controls, and tariffs.
  • Uncertain economic or social conditions, such as slow-downs, recessions, inflationary pressures, reduced market growth rates, and tighter credit markets for business partners.
  • Changing political and geopolitical conditions, including sanctions, trade barriers, and conflicts (e.g., Russia-Ukraine war), which could disrupt operations and impact financial results.
  • Disruptions in credit markets or to banking partners, or changes to credit ratings, which may reduce access to credit or overall liquidity.
  • Disruptions in the global supply chain, including labor disputes, loss of manufacturing sites, information system disruptions, inability to procure materials, natural disasters, and extreme weather events.
  • Cost fluctuations and pressures due to changes in prices of commodities, raw and packaging materials, labor, transportation, energy, pensions, and healthcare.
  • Intense competition from global and local competitors, including private-label brands, requiring successful response to pricing, promotional incentives, and evolving sales channels (e-commerce).
  • Significant changes in customer relationships or demand for products, including concentration among retail customers and potential reductions in inventory or shelf space.
  • Erosion of company or brand reputation due to product recalls, litigation, defects, changing consumer perceptions of ingredients/packaging, labor/social practices, privacy failures, or counterfeit products.
  • Reliance on third parties (suppliers, contract manufacturers, distributors) which creates financial, legal, reputational, and operational risks.
  • Information security or operational technology incidents, including cybersecurity threats, ransomware attacks, and misuse of AI/ML technologies, which could lead to operational disruptions, data breaches, and financial harm.
  • Challenges associated with future disease outbreaks, epidemics, or pandemics, potentially leading to reduced or volatile demand, supply chain issues, or governmental restrictions.
  • Failure to successfully innovate products, marketing, and operations, or respond to competitive innovation and evolving digital platforms.
  • Challenges in managing ongoing acquisition, joint venture, and divestiture activities, including potential dilutive impacts or failure to achieve expected synergies.
  • Inability to successfully manage productivity improvements and organizational change, including attracting and retaining key talent and executing leadership succession plans.
  • Compliance with current and expanding laws and regulations (intellectual property, product liability, environmental, privacy, tax, ESG matters) and managing new legal/regulatory matters.
  • Changes in applicable tax laws and regulations, and resolutions of tax disputes, which could negatively affect financial results.

Future Outlook

The company aims to deliver total shareholder return in the top one-third of its peer group through a long-term growth algorithm: organic sales growth above market rates, mid-to-high single-digit Core EPS growth, and adjusted free cash flow productivity of 90% or greater. It expects to incur approximately $1.5 billion to $2.0 billion in before-tax restructuring costs over a two-year period, with half by the end of fiscal 2026 and the remainder in fiscal 2027, including a reduction of up to 7,000 non-manufacturing overhead personnel. The termination of the Glad joint venture in January 2026 is expected to yield approximately $500 million in cash proceeds and an after-tax gain of $250 million to $300 million in the third quarter of fiscal year 2026. The company does not anticipate the 2025 U.S. Tax Act or the OECD Pillar Two global minimum tax to have a material impact on its financial condition, results of operations, cash flows, or effective tax rate.

Management Comments

  • Our business model is focused on delivering sustainable value creation by driving balanced topand bottom-line growth.
  • Our objective is to deliver sustainable and balanced topand bottom-line growth while serving the needs of all stakeholders – consumers, customers, employees, society and shareowners.
  • Our employees are a key source of competitive advantage. Their actions, guided by our Purpose, Values and Principles (PVPs), are critical to the long-term success of our business.
  • We believe that it is good for business that our workforce is drawn from the best available talent from communities worldwide, with insights about, connectivity to and understanding of all our consumers.
  • We believe this strategy is right for the long-term health of the Company and our objective of delivering total shareholder return in the top one-third of our peer group.
  • We believe our financial condition continues to be of high quality, as evidenced by our ability to generate substantial cash from operations and to readily access capital markets at competitive rates.

Industry Context

The company operates in a highly competitive global consumer goods industry, competing against a wide range of global and local players, including private-label brands. It differentiates itself through product superiority across five vectors: product performance, packaging, brand communication, retail execution, and value. The industry is experiencing evolving sales channels, with a growing consumer preference for online shopping and the emergence of hard discounter channels, which the company must successfully navigate to maintain its leadership or significant market share positions.

Comparison to Industry Standards

  • The company's common stock cumulative total return for the five-year period ended June 30, 2025, was $151 for a $100 investment, which lagged behind the S&P 500 Stock Index ($216) but was comparable to the S&P 500 Consumer Staples Index ($170).
  • The company's long-term growth algorithm targets total shareholder returns in the top one-third of its competitive, fast-moving consumer goods peer group, indicating an aspiration to outperform industry averages.
  • The company holds a global market leadership position in retail hair care (about 20% share), grooming (more than 45% share, over 60% in blades and razors), oral care (nearly 30% share), fabric care (over 35% share), and baby care (more than 30% share), demonstrating strong competitive positioning relative to industry standards in its key categories.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chairman of the Board, President and Chief Executive OfficerN/AJon R. Moeller2021Previously served as President and Chief Executive Officer (2021-2022), Vice Chairman, Chief Operating Officer and Chief Financial Officer (2019-2021), Vice Chairman and Chief Financial Officer (2017-2019), and Chief Financial Officer (2009-2017).
Chief Operating OfficerN/AShailesh Jejurikar2018Previously served as Chief Executive Officer Fabric and Home Care (2019-2021).
Chief Financial OfficerN/AAndre Schulten2021Previously served as Senior Vice President Baby Care, North America (2018-2021).
Chief Executive Officer Health CareN/AJennifer L. Davis2022Previously served as President Feminine Care (2019-2022).
Chief Executive Officer Baby, Feminine and Family CareN/AMa. Fatima D. Francisco2018Previously served as Chief Executive Officer Baby and Feminine Care (2019-2021).
Chief Executive Officer Beauty and Executive Sponsor for Corporate SustainabilityN/AR. Alexandra Keith2017Previously served as Chief Executive Officer Beauty (2017-2022).
Chief Executive Officer Fabric and Home CareN/ASundar Raman2021Previously served as President Home Care and P&G Professional (2020-2021) and President Fabric Care, North America and P&G Professional (2019-2020).
Chief Research, Development and Innovation OfficerN/AVictor Aguilar2020Previously served as Senior Vice President Research & Development, Corporate Function Research & Development (2020).
Chief Human Resources OfficerN/ABalaji Purushothaman2023Previously served as Senior Vice President Human Resources, Global Total Rewards, Employee and Labor Relations and Corporate Services (2020-2022) and as Senior Vice President Human Resources, Beauty, Grooming and Family Care (2015-2020).
Chief Legal Officer and SecretaryN/ASusan Street Whaley2022Previously served as Senior Vice President and General Counsel North America, Practice Groups and Sector Business Units (2019-2022).

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Oversight ResponsibilityThe Board of Directors oversees cybersecurity risks as part of its general risk oversight. The Audit Committee specifically reviews the security of electronic data processing information systems and general security of people, assets, and information systems.OngoingEnhances risk management and internal control effectiveness, providing assurance on financial reporting and data security.
Oversight ResponsibilityThe Compensation and Leadership Development Committee (C&LD Committee) provides oversight of the company's policies and strategy relating to talent, including equality and inclusion, and compensation principles and practices. It also evaluates and approves compensation plans for senior executives.OngoingEnsures alignment of talent strategy and compensation with business objectives and promotes a respectful and inclusive culture.
Organizational StructureEffective July 1, 2024, the Beauty reportable business segment separated Skin and Personal Care into individual operating segments, Skin Care and Personal Care, including separation of management teams, strategic decision-making, innovation plans, financial targets, budgets, and management reporting.July 1, 2024Aims to improve focus and agility within the Beauty segment by creating more specialized operating units, potentially leading to better performance and resource allocation in these categories.

Legal Proceedings

  • Procter & Gamble UK received notification on November 22, 2023, from the U.K. Environment Agency of its intent to assess an unspecified civil penalty for a prior inadvertent failure to secure a required permit under the European Union's and United Kingdom's Emission Trading Systems. The site has been properly registered since March 2021, and P&G UK proactively notified the agency.
  • In July 2025, the U.K. Environmental Agency notified P&G UK of its intent to impose a civil penalty of less than $2 million for the aforementioned permit issue. The matter is not yet resolved.

Related Party Transactions

  • The Procter & Gamble Profit Sharing Trust and Employee Stock Ownership Plan (ESOP) is maintained to provide a portion of the funding for the U.S. defined contribution plan and U.S. other retiree benefits. The ESOP holds Series A and Series B ESOP Convertible Class A Preferred Stock, which are considered plan assets for retiree benefits. The company provides advances to the ESOP and guarantees its debt, with $672 million outstanding at June 30, 2025.

Stakeholder Impact

  • Shareholders: Benefited from increased diluted EPS and Core EPS, and continued dividend increases (69 consecutive years). The company also executed a $6.5 billion share repurchase program in fiscal 2025. However, adjusted free cash flow productivity declined.
  • Employees: The company aims to retain talented employees through competitive compensation, career development, and an inclusive culture. However, the new portfolio and productivity plan includes a reduction of up to 7,000 non-manufacturing overhead personnel by the end of fiscal 2027, impacting a significant portion of the workforce.
  • Consumers: The company focuses on providing 'irresistibly superior' products across five key vectors (product performance, packaging, brand communication, retail execution, and value) and invests in R&D to meet evolving needs. Product and packaging investments were noted as a factor in gross margin decline.
  • Customers (Retailers): Sales to Walmart Inc. and its affiliates represent approximately 16% of total sales, and the top ten customers accounted for 43% of total net sales, indicating significant customer concentration. The company's success depends on managing these relationships and offering mutually acceptable trade terms.
  • Suppliers: The company has an ongoing program to negotiate extended payment terms and supports a Supply Chain Finance program, allowing participating suppliers to sell receivables to SCF banks, potentially providing more favorable terms for suppliers.
  • Creditors: The company maintains strong credit ratings (Aa3/AAlong-term) and access to capital markets, ensuring its ability to refinance debt and meet financial obligations.

Next Steps

  • Execute the portfolio and productivity plan, including a reduction of up to 7,000 non-manufacturing overhead personnel by the end of fiscal 2027.
  • Complete the substantial liquidation of operations in Argentina.
  • Terminate the Glad joint venture agreement in January 2026, with Clorox purchasing P&G's minority interest.
  • Continue to assess the overall impact of potential changes in tax laws, including Pillar Two global minimum tax, as developments occur.
  • Ongoing efforts toward reducing greenhouse gas emissions across scopes 1, 2, and elements of scope 3 as part of the 2040 net zero ambition.

Key Dates

DateDescription
1837Business founded in Cincinnati by William Procter and James Gamble.
1890Company first established as a New Jersey corporation; started paying dividends.
1905Company incorporated in Ohio.
1956Began increasing dividends for 69 consecutive years.
2005Acquisition of The Gillette Company.
October 23, 2017Effective date for tax law changes related to 1.250% Notes due 2029 tax redemption.
October 25, 2017Form 8-A filed for 1.250% Notes Due 2029.
June 30, 2020Start of the five-year period for cumulative total return comparison.
September 3, 2009Date of Indenture between the Company and Deutsche Bank Trust Company Americas.
October 24, 2018Effective date for tax law changes related to 1.200% Notes due 2028 and 1.875% Notes due 2038 tax redemption.
October 30, 2018Form 8-A filed for 1.200% Notes due 2028 and 1.875% Notes due 2038.
October 30, 2019Commencement of annual interest payments for 1.200% Notes due 2028 and 1.875% Notes due 2038.
December 2021Organisation for Economic Co-operation and Development (OECD) issued Pillar Two model rules for global minimum corporate tax rate.
March 2022Company reduced product portfolio, discontinued new capital investments, and suspended media/advertising/promotional activity in Russia due to ongoing war.
November 22, 2023Procter & Gamble UK received notification from the U.K. Environment Agency of intent to assess a civil penalty for a prior permit failure.
December 31, 2023Date of Gillette indefinite-lived intangible asset impairment charge calculation.
July 30, 2024Share repurchase program announced.
September 30, 2024Completion of limited market portfolio restructuring, including substantial liquidation of operations in Argentina.
October 1, 2024Annual impairment assessment of the Gillette Brand performed.
April 24, 2025Share repurchase program reaffirmed in earnings release.
June 2025Company announced a portfolio and productivity plan.
June 30, 2025Fiscal year end for the current report; end of share repurchase plan; number of common stock shareowners approximately 6 million.
July 1, 2024Beauty reportable business segment separated Skin and Personal Care into individual operating segments.
July 2025U.K. Environmental Agency notified P&G UK of intent to impose a civil penalty of less than $2 million.
July 2025U.S. government enacted the One Big Beautiful Bill Act (2025 U.S. Tax Act).
July 31, 2025Number of Common Stock shares outstanding was 2,342,371,488.
August 4, 2025Date of the 10-K filing and officer information.
October 2025Maturity of $4.8 billion 364-day credit facility.
January 2026Glad joint venture agreement termination date.
June 30, 2026Expected completion of half of the restructuring costs under the new portfolio and productivity plan.
June 30, 2027Expected completion of remaining restructuring costs and reduction of up to 7,000 non-manufacturing overhead personnel.
October 2028Maturity of 1.200% Notes.
October 25, 2029Maturity of 1.250% Notes.
May 3, 2029Maturity of 1.800% Notes.
October 2029Maturity of $3.2 billion five-year credit facility.
January 2030Maturity of 6.250% GBP Notes.
May 2027Maturity of 4.875% EUR Notes.
January 2033Maturity of 5.250% GBP Notes.
October 30, 2038Maturity of 1.875% Notes.
2040Company's net zero ambition target year.

Recommendation

hold

The company demonstrated solid financial performance with increased earnings and EPS, driven by effective cost management and strategic restructuring. Its strong brand portfolio and market leadership positions provide a stable foundation. However, the decline in operating cash flow and adjusted free cash flow productivity, coupled with ongoing significant restructuring costs and foreign exchange headwinds, suggest a period of transition. While the long-term outlook is positive with clear growth algorithms, the immediate future involves managing these operational and financial adjustments. A 'hold' recommendation is appropriate as the company navigates these changes, with potential for 'buy' once the benefits of restructuring are more clearly realized and cash flow trends improve.

Keywords

Consumer Goods, CPG, Household Products, Personal Care, Beauty, Grooming, Health Care, Fabric Care, Home Care, Baby Care, Feminine Care, Family Care, SEC Filing, 10-K, Financial Results, Earnings, Cash Flow, Restructuring, Divestiture, Share Repurchase, Dividends, Global Operations, Supply Chain, Cybersecurity, ESG

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.